BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 9365887)

  • 1. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P; Siegl G; Michel BA; Brühlmann P
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
    Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
    Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
    Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
    Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
    J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
    J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
    Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
    J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
    Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
    Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
    Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
    Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
    Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
    Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
    Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
    Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
    Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.